| |
| |
|
| Insider
Information: |
Aberman Michael S |
| Relationship: |
SVP Strategy Investor ... |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,693 |
|
|
Indirect Shares
|
12,253 |
|
|
| Direct
Value |
$4,491,201 |
|
|
|
Indirect Value
|
$11,726,121 |
|
|
| Total
Shares |
16,946 |
|
|
| Total
Value |
$16,217,322 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
SVP Strategy Investor ... |
2017-06-22 |
4,693 |
2017-06-22 |
12,253 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2017-06-22 |
4 |
AS |
$525.21 |
$1,208,061 |
D/D |
(2,269) |
4,693 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2017-06-21 |
4 |
D |
$510.02 |
$1,137,855 |
D/D |
(2,231) |
6,962 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2017-06-21 |
4 |
OE |
$30.63 |
$137,835 |
D/D |
4,500 |
9,193 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-12-17 |
4 |
OE |
$24.00 |
$96,000 |
D/D |
4,000 |
16,498 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-03-24 |
4 |
AS |
$474.79 |
$2,319,738 |
D/D |
(4,843) |
12,498 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-03-23 |
4 |
D |
$476.50 |
$2,457,311 |
D/D |
(5,157) |
17,341 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-03-18 |
4 |
AS |
$462.84 |
$1,600,542 |
D/D |
(3,442) |
22,498 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-03-17 |
4 |
D |
$457.91 |
$1,858,199 |
D/D |
(4,058) |
25,940 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-03-17 |
4 |
OE |
$24.00 |
$273,552 |
D/D |
11,398 |
29,998 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-02-24 |
4 |
AS |
$416.31 |
$1,411,952 |
D/D |
(3,374) |
18,600 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-02-23 |
4 |
D |
$427.94 |
$1,765,680 |
D/D |
(4,126) |
21,974 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-02-23 |
4 |
OE |
$30.63 |
$229,725 |
D/D |
7,500 |
26,100 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-02-17 |
4 |
AS |
$401.54 |
$1,493,266 |
D/D |
(3,692) |
18,600 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-02-13 |
4 |
D |
$402.05 |
$1,531,006 |
D/D |
(3,808) |
22,292 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
• – – |
2015-02-13 |
4 |
OE |
$24.00 |
$180,000 |
D/D |
7,500 |
26,100 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-08-22 |
4 |
OE |
$24.00 |
$72,000 |
D/D |
3,000 |
18,600 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-08-19 |
4 |
AS |
$350.00 |
$1,263,850 |
D/D |
(3,611) |
15,600 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-08-18 |
4 |
OE |
$52.03 |
$455,263 |
D/D |
8,750 |
24,350 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-08-18 |
4 |
D |
$351.06 |
$1,804,097 |
D/D |
(5,139) |
19,211 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-02-18 |
4 |
AS |
$324.81 |
$1,209,036 |
D/D |
(3,648) |
15,600 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-02-14 |
4 |
D |
$323.30 |
$1,245,352 |
D/D |
(3,852) |
19,248 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2014-02-14 |
4 |
OE |
$30.63 |
$229,725 |
D/D |
7,500 |
23,100 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2013-06-17 |
4 |
OE |
$24.00 |
$93,600 |
D/D |
3,900 |
15,600 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2013-05-14 |
4 |
AS |
$278.72 |
$1,545,960 |
D/D |
(5,529) |
11,700 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
• – – |
2013-05-13 |
4 |
D |
$275.97 |
$1,923,787 |
D/D |
(6,971) |
17,229 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
